Compound information
- Natural Products
- ZC2751190
- Molecular Formula
- C32H37N3O7
- Molecular Weight
- 575.263150524 g/mol
- Structure
-
- IUPAC Name
- methyl (2R)-2-[[(2R)-2,6-bis(benzyloxycarbonylamino)hexanoyl]amino]-3-phenyl-propanoate
- InChI
- InChI=1S/C32H37N3O7/c1-40-30(37)28(21-24-13-5-2-6-14-24)34-29(36)27(35-32(39)42-23-26-17-9-4-10-18-26)19-11-12-20-33-31(38)41-22-25-15-7-3-8-16-25/h2-10,13-18,27-28H,11-12,19-23H2,1H3,(H,33,38)(H,34,36)(H,35,39)/t27-,28-/m1/s1
- InChI Key
- DZYKZAAHHBDWBC-VSGBNLITSA-N
- SMILES
- COC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](CCCCNC(=O)OCc1ccccc1)NC(=O)OCc1ccccc1
- Source
- ZINC000100814643
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 42 | Ring Count | 3 |
Heteroatom Count | 10 | Rotatable Bond Count | 15 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 132.06 Å2 | LogP | 4.538 |
LogS | -5.929 | LogD | 4.469 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.991 | Pgp substrate | 0.819 |
HIA | 0.97 | F20 % | 0.969 |
F30 % | 0.0 | Caco-2 | -5.228 |
MDCK | -4.867 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.004 | PPB | 93.565 |
VD | 0.337 | Fu | 1.876 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.146 | CYP1A2 substrate | 0.626 |
CYP2A6 substrate | 0.241 | CYP2B6 substrate | 0.426 |
CYP2C19 inhibitor | 0.966 | CYP2C19 substrate | 0.394 |
CYP2C8 substrate | 0.705 | CYP2C9 inhibitor | 0.911 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.328 |
CYP2D6 substrate | 0.682 | CYP2E1 substrate | 0.443 |
CYP3A4 inhibitor | 0.992 | CYP3A4 substrate | 0.994 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.754 | CL | 3.009 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.621 | Hepatotoxicity | 0.914 |
Mutagenicity | 0.167 | Rat Oral Acute Toxicity | 0.309 |
FDAMDD | 0.557 | Skin Sensitization | 0.006 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.005 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.009 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.903 | IGC50 | 4.909 |
LC50FM | 4.446 | LC50DM | 5.134 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.238 | NR-AR-LBD | 0.205 |
NR-AhR | 0.005 | NR-Aromatase | 0.03 |
NR-ER | 0.302 | NR-ER-LBD | 0.387 |
NR-PPAR-gamma | 0.234 | SR-ARE | 0.636 |
SR-ATAD5 | 0.428 | SR-HSE | 0.145 |
SR-MMP | 0.468 | SR-p53 | 0.09 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.